PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Analyze analyst forecasts for the company and compare them with competitors.
1.17M
No peer data available for comparison.
-234.73K
No peer data available for comparison.
-1.16
No peer data available for comparison.
-30.77M
No peer data available for comparison.
-234.73K
No peer data available for comparison.
43.49M
No peer data available for comparison.
Analyze DCF forecasts for the company and compare them with competitors.
No Data
No DCF data available for this metric in the selected year.
-100.00%
Worse than BTAI's revenue growth rate of 64.20%.
-37.43M
Better than BTAI's ebitda of -44.16M.
100.00%
Better than BTAI's ebitda margin of -1948.85%.
-38.24M
Better than BTAI's ebit of -44.47M.
100.00%
Better than BTAI's ebit margin of -1962.49%.
811.00K
Worse than BTAI's depreciation of 309.00K.
72.90M
Better than BTAI's total cash of 29.85M.
100.00%
Worse than BTAI's cash as percentage of revenue of 1317.48%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Worse than BTAI's receivables as percentage of revenue of 5.78%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Worse than BTAI's inventories as percentage of revenue of 29.96%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Better than BTAI's payables as percentage of revenue of 705.65%.
-11.00K
Better than BTAI's capital expenditure of 0.00.
100.00%
Worse than BTAI's capex as percentage of revenue of 0.00%.
4.99%
Better than BTAI's weighted average cost of capital (wacc) of 14.36%.
5.02%
Worse than BTAI's cost of equity of 5.00%.
4.08%
Better than BTAI's cost of debt of 14.70%.
-0.23
Better than BTAI's beta of 0.08.
30.07M
Worse than BTAI's diluted shares outstanding of 2.54M.
1.57M
Better than BTAI's total debt of 102.95M.
49.31M
Better than BTAI's total equity of 3.68M.
50.89M
Worse than BTAI's total capital of 106.62M.
3.09%
Better than BTAI's debt weighting of 96.55%.
96.91%
Better than BTAI's equity weighting of 3.45%.
-38.24M
Better than BTAI's ebiat of -44.47M.
-45.40M
Worse than BTAI's unlevered free cash flow of -40.57M.
2.00%
Equal to BTAI's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than BTAI's net debt of 73.09M.
71.33M
Better than BTAI's equity value of -68.25M.
2.37
Better than BTAI's equity value per share of -26.92.
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.